| |
| |
|
| Insider
Information: |
Harrington Michael J |
| Relationship: |
Director |
| City: |
Indianapolis |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
156,394 |
|
|
Indirect Shares
|
59,952 |
|
|
| Direct
Value |
$44,621,267 |
|
|
|
Indirect Value
|
$54,515,553 |
|
|
| Total
Shares |
216,346 |
|
|
| Total
Value |
$99,136,819 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-2.0
|
0.0
|
| Percentage
Gain/Loss : |
 -100.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eli Lilly & Co |
LLY |
Senior VP and General ... |
2019-10-24 |
47,800 |
2019-10-24 |
59,952 |
Premium* |
|
|
Elanco Animal Health Inc |
ELAN |
|
2024-08-22 |
81,094 |
2019-04-11 |
0 |
Premium* |
|
|
Inotiv Ord Shs |
NOTV |
Director |
2024-08-10 |
27,500 |
2024-08-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
41 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
• – – |
2016-02-01 |
4 |
D |
$79.10 |
$331,745 |
D/D |
(4,194) |
59,915 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
• – – |
2017-02-01 |
4 |
D |
$77.03 |
$349,947 |
D/D |
(4,543) |
84,889 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
• – – |
2018-02-01 |
4 |
D |
$81.45 |
$880,556 |
D/D |
(10,811) |
91,927 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
• – – |
2019-02-01 |
4 |
D |
$119.86 |
$527,863 |
D/D |
(4,404) |
98,144 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
• – – |
2019-02-11 |
4 |
GA |
$0.00 |
$0 |
I/I |
62,500 |
62,500 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
• – – |
2015-11-25 |
5 |
GD |
$0.00 |
$0 |
D/D |
2,276 |
37,082 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
• – – |
2019-02-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
62,500 |
47,800 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
• – – |
2019-10-24 |
4 |
GD |
$0.00 |
$0 |
I/I |
3,000 |
59,500 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Senior VP and General CounselO |
• – – |
2013-01-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
376 |
|
- |
|
| LLY |
Eli Lilly & Co |
Senior VP and General CounselO |
• – – |
2013-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
15,568 |
|
- |
|
| LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
• – – |
2014-08-12 |
4 |
OE |
$55.65 |
$151,479 |
D/D |
2,722 |
32,293 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
• – – |
2015-04-28 |
4 |
OE |
$56.18 |
$338,428 |
D/D |
6,024 |
44,542 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
• – – |
2016-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,066 |
64,109 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
• – – |
2017-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,732 |
89,432 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
• – – |
2018-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,524 |
102,738 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
• – – |
2019-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,778 |
102,548 |
0 |
- |
|
41 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
